Tennessee Comprehensive Lung and Sleep Center offers a gateway to the frontiers of research and development in the field of pulmonary medicine.  Pharmaceutical companies ask our physicians to serve as primary investigators for their studies in the development of treatments for diseases like asthma and COPD.  Within the framework of our center, we have a research team that allows us to screen patients for immediate consideration in new and innovative therapeutic studies.

If you are interested in participating in one of our research studies, please contact our clinical research department at:

Email: kim@lungandsleeptn.com or Phone: (615) 431-0469

 

Currently Enrolling Clinical Trials at Our Site:

 

 


Oncocyte (Pulmonary Nodules)


A study to evaluate a panel of blood biomarkers for use in patients undergoing evaluation for lung cancer.


PASS (COPD)

This is a post-marketing observational study comparing the cardiovascular and cerebrovascular events in COPD patients using Anoro, Incuse or Spiriva.

Kimberly_McKenzie.jpg

      Kimberly McKenzie,
Clinical Research Manager

Kimberly McKenzie graduated with a B.A. in Psychology from the University of Tennessee, Knoxville in 2009. During her college career, she did undergraduate research on circadian rhythms and an internship at the Center for Narcolepsy, Sleep and Health Research in Chicago. After spending a year working and traveling abroad after college graduation, she wanted to pursue her interest in clinical research. After completing a Clinical Research Associate training program in the spring of 2011, she began her career at Carolina Urologic Research Center in Myrtle Beach. She worked on various urological studies as a Clinical Research Coordinator, with a focus on bladder cancer. In 2013, she moved to Nashville to continue oncology research as a Clinical Trial Specialist at Sarah Cannon Research Institute. She is eager to use her knowledge and expertise to grow and manage the clinical research program at Tennessee Comprehensive Lung and Sleep Center.